31 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19045166 | STABLE, AQUEOUS FORMULATIONS OF ANTIBODIES THAT BIND IL5 RECEPTOR | KIM, YUNSOO | 1641 | Final Rejection | Feb 04, 2025 |
| 18855182 | PREDICTING ALBUMINURIA USING MACHINE LEARNING | HEIN, DEVIN C | 3686 | Non-Final OA | Oct 08, 2024 |
| 18443829 | SPIROCYCLIC COMPOUNDS | HABTE, KAHSAY | 1624 | Non-Final OA | Feb 16, 2024 |
| 18421142 | COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS | STAVROU, CONSTANTINA E | 1632 | Non-Final OA | Jan 24, 2024 |
| 18564778 | METHODS OF TREATING BREAST CANCER | FETTEROLF, BRANDON J | 1626 | Non-Final OA | Nov 28, 2023 |
| 18492216 | METHODS OF TREATMENT OF BREAST CANCER | SCHMIDT, IZABELA MARIA | 1621 | Non-Final OA | Oct 23, 2023 |
| 18552014 | FORMULATION COMPRISING CERALASERTIB | LEE, SIN J | 1613 | Final Rejection | Sep 22, 2023 |
| 18470548 | PCSK9 INHIBITORS AND METHODS OF USE THEREOF | JACKSON, SHAWQUIA | 1626 | Non-Final OA | Sep 20, 2023 |
| 18550548 | CONTROL OF MULTI-GENE EXPRESSION USING SYNTHETIC PROMOTERS | SMITH, ADAM MICHAEL | 1638 | Non-Final OA | Sep 14, 2023 |
| 18550546 | SYSTEM AND METHOD FOR ONLINE DETECTION OF A POST-TRANSLATIONAL MODIFICATION OF A POLYPEPTIDE | BERKE-SCHLESSEL, DAVID W | 1651 | Non-Final OA | Sep 14, 2023 |
| 18452008 | PHARMACEUTICAL PROCESS AND INTERMEDIATES | OH, TAYLOR V | 1625 | Non-Final OA | Aug 18, 2023 |
| 18448559 | COMBINATION THERAPIES FOR TREATMENT OF CIRRHOSIS WITH PORTAL HYPERTENSION | REDWOOD, CHRISTOPHER EVAN | 1629 | Non-Final OA | Aug 11, 2023 |
| 18264526 | NEW METHOD TO PRONOSTIC LUNG CANCER | VOLKOV, ALEXANDER ALEXANDROVIC | 1677 | Non-Final OA | Aug 07, 2023 |
| 18262934 | CLINICAL ENDPOINT ADJUDICATION SYSTEM AND METHOD | PATEL, SHERYL GOPAL | 3685 | Final Rejection | Jul 26, 2023 |
| 18337476 | N-(2-(3-CYANO-2-AZABICYCLO[3.1.0]HEXAN-2-YL)-2-OXOETHYL)QUINOLINE-4-CARBOXAMIDES | MCDOWELL, BRIAN E | 1624 | Non-Final OA | Jun 20, 2023 |
| 18257123 | N-(2-(4-CYANOTHIAZOLIDIN-3-YL)-2-OXOETHYL)-QUINOLINE-4-CARBOXAMIDES | ANDERSON, REBECCA L | 1626 | Final Rejection | Jun 13, 2023 |
| 18253280 | STEROID SPARING | HADDAD, MAHER M | 1641 | Non-Final OA | May 17, 2023 |
| 18248280 | TREATMENT OF FLARES IN LUPUS | XIE, XIAOZHEN | 1674 | Non-Final OA | Apr 07, 2023 |
| 18247014 | COMPOUNDS AND THEIR USE IN TREATING CANCER | TOWNSLEY, SARA ELIZABETH | 1629 | Non-Final OA | Mar 28, 2023 |
| 18171735 | Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer | AULAKH, CHARANJIT | 1621 | Non-Final OA | Feb 21, 2023 |
| 17926235 | TUMOR MUTATIONAL BURDEN ASSOCIATED WITH SENSITIVITY TO IMMUNOTHERAPY IN LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA | AEDER, SEAN E | 1642 | Non-Final OA | Nov 18, 2022 |
| 18056367 | LIPIDS FOR DELIVERY OF NUCLEIC ACID SEGMENTS | PYLA, EVELYN Y | 1633 | Non-Final OA | Nov 17, 2022 |
| 17998275 | ATR INHIBITORS FOR THE TREATMENT OF CANCER | HIRAKIS, SOPHIA P | 1623 | Non-Final OA | Nov 09, 2022 |
| 18046173 | COMBINATION | REDDIG, PETER J | 1646 | Final Rejection | Oct 13, 2022 |
| 17917333 | COMPOSITIONS AND METHODS FOR IMPROVED SITE-SPECIFIC MODIFICATION | ALLEN, SARAH ELIZABETH | 1637 | Non-Final OA | Oct 06, 2022 |
| 17755801 | TYPE I INTERFERON INHIBITION IN SYSTEMIC LUPUS ERYTHEMATOSUS | KIM, YUNSOO | 1641 | Final Rejection | May 09, 2022 |
| 17772187 | DRY POWDER FORMULATIONS CONTAINING LEUCINE AND TRILEUCINE | HAGHIGHATIAN, MINA | 1616 | Non-Final OA | Apr 27, 2022 |
| 17765585 | METHODS AND COMBINATIONS FOR THE TREATMENT OF CANCER USING IMMUNE CHECKPOINT INHIBITOR ANTIBODIES | CHATTIN, AMY MARIE | 1643 | Non-Final OA | Mar 31, 2022 |
| 17754258 | COMBINATION TREATMENT FOR CANCER | DARPOLOR, JOSEPHINE KEBBEH | 1642 | Non-Final OA | Mar 29, 2022 |
| 17529574 | Compositions and Methods for Treating Late Stage Lung Cancer | HECK, BRYAN WILLIAM | 1643 | Non-Final OA | Nov 18, 2021 |
| 17318017 | METHODS AND COMBINATIONS FOR THE TREATMENT OF CANCER USING IMMUNE CHECKPOINT INHIBITOR ANTIBODIES | BUTTICE, AUDREY L | 1647 | Final Rejection | May 12, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial